Camp4 Therapeutics

CAMPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$261.681 M

$4.17 -1.65%

Close of 21 Sept 2026

Revenue

$3.50M

#3340 by revenue

Earnings

-$80.4M

Loss-making

Shares outstanding

62,753,200

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#247ProQR TherapeuticsPRQR$262.5M
#248MacrogenicsMGNX$262.4M
#249Camp4 TherapeuticsCAMP$261.7M
#250Akebia TherapeuticsAKBA$260.1M
#251Entrada TherapeuticsTRDA$258.5M

Insiders buying

All insider buying →

4 open-market purchases by officers and directors of Camp4 Therapeutics, worth $59.5K. Grants and option exercises are excluded.

Richard A. Young$27.0K
16,378 shares at $1.65 on 3 Aug 2026 · filed 5 Aug 2026
Josh Mandel-BrehmChief Executive Officer$10.8K
6,551 shares at $1.65 on 3 Aug 2026 · filed 5 Aug 2026
Kelly GoldChief Financial Officer$10.8K
6,551 shares at $1.65 on 3 Aug 2026 · filed 5 Aug 2026
Yuri MaricichChief Medical Officer$10.8K
6,551 shares at $1.65 on 3 Aug 2026 · filed 5 Aug 2026

What if Camp4 Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$482,430.44

Per share 115,691× higher

Bitcoin $1.72T

$27,405.83

Per share 6,572× higher

Nvidia $5.48T

$87,323.96

Per share 20,941× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Camp4 Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.